Boeing's third quarter was a split decision. The core loss of $0.34 per share beat the Earnings Whisper number of -$0.45 by 24.4%, but it was wider than the -$0.21 consensus. Revenue of $24.188 billion rose 3.9% year over year and missed the $24.28 billion consensus by 0.4%. Earnings improved 95.4% from a year ago, when the 777X charge produced a $7.47 core loss, and GAAP operating results swung to a $354 million profit from a $4.78 billion loss. The more important trend runs the other way. Revenue growth has slowed from 14% in the first quarter to 8% in the second and roughly 4% now. Management also used the call to push nearly every commercial milestone further out. That is the central tension: the defense franchise and the backlog have never looked stronger, while the commercial recovery that drives the equity story just moved a year to the right.

The quality of the quarter deserves scrutiny. Consolidated operating margin improved to 1.5% from 0.6% in the second quarter, and the core loss narrowed from -$0.76. Much of that improvement came from outside Commercial Airplanes. Defense, Space & Security posted a 6.2% margin, but $252 million of its $492 million operating profit came from the HRL Laboratories sale. Global Services was the clean performer, with an 18.3% margin and 11% organic growth. Commercial Airplanes went the wrong way. Its margin deteriorated to -6.5% from -2.7% in the second quarter on a less favorable delivery mix, higher projected costs from production-rate adjustments and higher supply-chain costs. Revenue in the segment fell 3% on essentially flat deliveries of 161 airplanes. Cash was better than feared. Free cash flow of $464 million beat the second-quarter guide for the 'low hundreds of millions' despite roughly $700 million of Department of Justice settlement payments. Debt held at $45.9 billion against $20.7 billion of cash and investments.

The call documented a broad reset of commercial expectations:

• **737 rates:** Wing flow-enabler shortfalls pushed rate-47 stability into 2027, and rate 52 is now targeted for the second half of 2027.
• **737 deliveries:** Shipments will fall short of the 500-unit target that management had reaffirmed for three straight quarters.
• **787:** Deliveries are guided to the low end of 90-100 as the move to rate 10 slips.
• **777F and 767:** A wing-component supplier disruption will carry abnormal costs into the first half of 2027.
• **Margins:** Commercial breakeven moved to early 2028, from the first quarter's goal of positive margins by mid-2027. Management also conceded that 737 margins will not return to 2018 levels, a retreat from second-quarter language.

The offset is real. The 737-7 and 737-10 both won FAA certification, which removes a key 2026 risk and frees about 30 pre-built aircraft for delivery in 2027. Defense momentum accelerated:

• The F/A-XX selection adds to the F-47 award, though F/A-XX is not yet in backlog.
• A seven-year PAC-3 seeker contract should eventually triple production.
• Boeing added 22 more F-15EX aircraft to its contracts.
• Starliner now has a path forward with $359 million of additional NASA funding.

Defense backlog jumped to $101 billion from $85 billion on $23 billion of quarterly orders, and the CEO lifted the defense growth outlook to mid-single digits or higher. Total backlog reached a record $745 billion. A new SPEEA engineering contract also eliminated the strike risk flagged last quarter.

The new multi-year free-cash-flow framework is the most consequential forward-looking disclosure. Management now targets about $2 billion in 2026, narrowed from $1-3 billion, followed by about $3 billion in 2027, about $6 billion in 2028 and $10 billion in 2029. The concreteness is welcome, but the CEO himself called the profile a one-year shift to the right. The 2027 figure is weighed down by a few billion dollars of lower commercial deposits and roughly $5 billion of capex. Normalized capex is now expected at 3-4% of revenue, versus about 2% historically. The 777X remains a swing factor: planning assumes certification by mid-2027, with ETOPS and flight-test authorization still pending.

The market had largely anticipated disappointment. Shares entered the report at $188.31, down 12% since the open after the July report. That price sits 13.8% below the 200-day moving average, about 22% below the August 5 inter-earnings high of $241.09 and only 3.2% above the October 23 low. Investor sentiment slipped from a slightly positive 0.06 to a mildly negative -0.08. That is a modest shift, but it means expectations were no longer leaning bullish. The Earnings Whispers trend readings are mixed: price and AVWAP trends are negative, while momentum is positive.

The bottom line is that Boeing delivered a quarter that turnaround bulls and skeptics can both use. Certifications, a record backlog, accelerating defense wins and a hard cash roadmap strengthen the long-term case. Bears have legitimate ammunition, though, in a deteriorating commercial margin, slipping production rates, structurally higher capex and a $10 billion cash target that is now a 2029 event. With the stock already pinned near its quarterly low, the next test is execution against these reset timelines rather than another round of promises.